natgillin/translations-raw huggingface dataset:
The doses used in adolescents above 12 years old were similar to the doses used in adults’ patients with endogenous Cushing’s syndrome.
Odmerki, ki so jih uporabili pri mladostnikih, starejših od 12 let, so bili podobni kot pri odraslih z endogenim Cushingovim sindromom.
The dosimetry estimates were based on a mouse distribution study and the calculations were effected using OLINDA - Organ Level INternal Dose Assessment Code (see Table 2).
Dozimetrične ocene temeljijo na študiji porazdelitve pri miših, izračuni pa so bili izvedeni z ocenjevalnim kodeksom OLINDA (Organ Level INternal Dose Assessment Code) (glejte preglednico 2).
The dosimetry estimates were based on a rat biodistribution study performed according to MIRD pamphlet no.16, and the calculations were performed using the OLINDA 1.1 software package.
Dozimetrične ocene temeljijo na študiji biološke porazdelitve pri podganah v skladu s publikacijo MIRD št.
The dosimetry table below is presented in order to evaluate the contribution of non-conjugated 64Cu to the radiation dose following the administration of 64Cu-labelled medicinal product or resulting from an accidental intravenous injection of Cuprymina.
Spodnja preglednica dozimetrije predstavlja ocenjevanje prispevka nekonjugiranega bakra (64Cu) k prejetemu odmerku sevanja po dajanju z bakrom (64Cu) označenega zdravila ali kot rezultat naključne intravenske injekcije radiofarmacevtskega predhodnika Cuprymina.
The dosimetry table below is presented in order to evaluate the contribution of non-conjugated Yttrium (90Y) to the radiation dose following the administration of Yttrium (90Y)-labelled medicinal product or resulting from an accidental intravenous injection of YTRACIS.
Spodnja preglednica o dozimetriji omogoča oceno doze sevanja, ki jo prispeva nekonjugirani itrij (90Y) po aplikaciji zdravila, označenega z itrijem (90Y), ali po naključni intravenski injekciji zdravila YTRACIS.
The dosing and titration concept;
koncept odmerjanja in titriranja;
The dosing interval may be adjusted by your doctor depending upon your response to Cinryze.
Presledek med odmerki lahko vaš zdravnik prilagodi vašemu odzivu na zdravilo Cinryze.
The dosing pump has to be removed from the plastic bag (fig.
Odmerno črpalko vzamemo iz plastične vrečke (sl.
The dosing pump head has two positions and is easy to turn – anticlockwise (unlocked position) and clockwise (locked position).
Glava odmerne črpalke ima dva položaja in jo zlahka obračamo – v obratni smeri urnega kazalca (odklenjen položaj) in v smeri urnega kazalca (zaklenjen položaj).
The dosing pump head has two positions and is easy to turn:
Glava odmerne črpalke ima dva položaja in jo zlahka obračamo:
The dosing recommendation is applicable to the recommended dose of simeprevir 150 mg once daily.
Priporočilo za odmerjanje se nanaša na priporočeni odmerek 150 mg simeprevirja enkrat na dan.
The dosing recommendations described in ‘Use in adults’ apply to patients with mild to moderate renal impairment (creatinine clearance = 30 - 80 mL/min).
Priporočila za odmerjanje, opisana pri ‘Uporaba pri odraslih’, veljajo tudi za bolnike z blago do zmerno okvaro ledvic (očistek kreatinina = 30 - 80 ml/min).
The dosing recommendations described in ‘Use in adults’ apply to patients with mild to moderate renal impairment (creatinine clearance = 30-80 ml/min).
Priporočila za odmerjanje (glejte odstavek Uporaba pri odraslih) veljajo tudi za bolnike z blago do zmerno ledvično okvaro (očistek kreatinina 30 do 80 ml/min).
The dosing recommendations described in ‘Use in adults’ apply to patients with mild to moderate renal impairment (creatinine clearance = 30-80 mL/min).
Priporočila za odmerjanje, opisana pri "Uporaba pri odraslih", veljajo tudi za bolnike z blago do zmerno okvaro ledvic (očistek kreatinina = 30 do 80 ml/min).
The dosing recommendations described in ‘Use in adults’ apply to patients with mild to moderate renal impairment (creatinine clearance=30-80 mL/min).
Priporočila za odmerjanje, opisana pri "Uporaba pri odraslih", veljajo tudi za bolnike z blago do zmerno okvaro ledvic (očistek kreatinina = 30 do 80 mL/min).
The dosing recommendations for paediatric patients aged 2 to 17 years with transfusional iron overload are the same as for adult patients.
Priporočeno odmerjanje za pediatrične bolnike, ki so stari od 2 do 17 let in imajo preobremenitev z železom zaradi transfuzij, je enako kot za odrasle.
The dosing regimen of Kalydeco may need to be adjusted in patients taking certain types of medicines.
Režim odmerjanja zdravila Kalydeco bo pri bolnikih, ki jemljejo določena druga zdravila, morda treba prilagoditi.
The dosing regimen of the lamivudine component of DUTREBIS in the paediatric population is the same as the dosing regimen of the individual component (EPIVIR).
Odmerjanje lamivudina v zdravilu DUTREBIS je v pediatrični populaciji enako odmerjanju samega lamivudina (zdravilo EPIVIR).
The dosing schedule is presented in Table 1.
Shema odmerjanja je prikazana v tabeli 1.
The dosing scheme used was 35 IU/kg/month (every 28 days +/- 2 days).
Uporabljena shema za odmerjanje je bila 35 i.e./kg/mesec (vsakih 28 dni +/- 2 dni).
The dosing syringe and cap are to be used once and then discarded.
Vsebino odmerne brizge uporabite naenkrat, odmerno brizgo skupaj z zaščitnim pokrovčkom pa potem vrzite stran.
The dosing syringe should be used to withdraw the prescribed amount of Rapamune from the bottle.
S pomočjo odmerne brizge vzamemo potrebno količino zdravila Rapamune iz steklenice.
The dosing table provides the number of dots to be administered corresponding to the dog’s bodyweight.
V preglednici za odmerjanje je prikazano število pik, ki jih je treba dati glede na telesno težo psa.
The dosing table provides the number of dots to be administered corresponding to the dog’s bodyweight.
V preglednici za odmerjanje je prikazano število pik, ki jih je treba dati živali glede na telesno težo psa.
The double non-nucleoside study 2 NN was a randomised, open-label, multicentre prospective study comparing the NNRTIs nevirapine, efavirenz and both medicinal products given together.
Dvojna nenukleozidna študija 2NN je bila odprta, multicentrična prospektivna študija pri naključno izbranih bolnikih, v kateri so primerjali nenukleozidni zaviralec reverzne transkriptaze zdravilo nevirapin, efavirenz in obe zdravili pri hkratni uporabi.
The double-blind period was followed by an open-label period during which patients receive Humira 40 mg every other week subcutaneously for up to an additional 144 weeks.
Dvojno slepi periodi je sledila odprta perioda, v kateri so bolniki prejemali zdravilo Humira 40 mg vsak drug teden subkutano do dodatnih 144 tednov.
The double–blind study population comprised 832 male patients of whom 551 patients received Xiapex and 281 received placebo.
Populacijo dvojno slepe študije je sestavljalo 832 moških bolnikov, od katerih je 551 bolnikov prejemalo zdravilo Xiapex in 281 jih je prejemalo placebo.
The dressed wound must be covered with a loose, thick fluffy dressing, held in place with a bandage.
Rano z oblogo morate prekriti z ohlapno, debelo in kosmičavo oblogo ter jo pritrditi z ovojem.
The dressing must remain in place for 4 hours.
Obloga mora ostati na rani 4 ure.
The drip (infusion) lasts for about 1 hour.
Kapalna (infuzija) traja približno 1 uro.
The drip will be stopped straight away.
Infundiranje bo takoj prekinjeno.
The drops can be mixed with water, juice or other non-alcoholic drinks.
Kapljice se lahko meša z vodo, s pomarančnim sokom ali z drugimi brezalkoholnimi pijačami.
The drug substance, tilmanocept, specifically binds to mannose binding receptor proteins (CD206) that reside on the surface of macrophages and dendritic cells.
Zdravilna učinkovina, tilmanocept, se specifično veže na receptorske proteine (CD206), ki vežejo manozo in so na površini makrofagov in dendritičnih celic.
The DTPa-HBV-IPV suspension should be well shaken in order to obtain a homogeneous turbid white suspension.
Pred uporabo je treba suspenzijo DTPa-HBV-IPV dobro pretresti, da dobimo homogeno, motno belo suspenzijo.
The DTPa-HBV-IPV suspension should be well shaken in order to obtain a homogeneous turbid white suspension.
Suspenzijo DTPa-HBV-IPV je treba dobro pretresti, da nastane homogena, motna bela suspenzija.
The durability of effect on beta-cell function was maintained through 52 weeks.
Učinek na beta celice je trajal vseh 52 tednov.
The duration of action lasts approximately 6 hours.
Delovanje traja približno 6 ur.
The duration of action of the insulin lispro protamine suspension (BASAL) component of Humalog Mix25 is similar to that of a basal insulin (NPH).
Trajanje delovanja sestavine zdravila Humalog Mix25 suspenzije insulina lispro-protamin (BASAL) je podobno kot pri bazalnem insulinu (NPH).
The duration of action of the insulin lispro protamine suspension (BASAL) component of Humalog Mix25 is similar to that of a basal insulin NPH.
Trajanje delovanja sestavine zdravila Humalog Mix25 suspenzije insulina lispro-protamin (BASAL) je podobno kot pri bazalnem insulinu (NPH).
The duration of action of the insulin lispro protamine suspension (BASAL) component of Humalog Mix50 is similar to that of a basal insulin (NPH).
Trajanje delovanja sestavine zdravila Humalog Mix50 suspenzije insulina lispro-protamin (BASAL) je podobno kot pri bazalnem insulinu (NPH).
The duration of action of the insulin lispro protamine suspension (BASAL) component of Humalog Mix50 is similar to that of a basal insulin NPH.
Trajanje delovanja sestavine zdravila Humalog Mix50 suspenzije insulina lispro-protamin (BASAL) je podobno kot pri bazalnem insulinu (NPH).
The duration of action of the insulin lispro protamine suspension (Basal) component of Liprolog Mix25 is similar to that of a basal insulin (NPH).
Trajanje delovanja sestavine zdravila Liprolog Mix25 suspenzije insulina lispro-protamin (Basal) je podobno kot pri bazalnem insulinu (NPH).
The duration of action of the insulin lispro protamine suspension (Basal) component of Liprolog Mix25 is similar to that of a basal insulin NPH.
Trajanje delovanja sestavine zdravila Liprolog Mix25 suspenzije insulina lispro-protamin (Basal) je podobno kot pri bazalnem insulinu (NPH).
The duration of action of the insulin lispro protamine suspension (Basal) component of Liprolog Mix50 is similar to that of a basal insulin (NPH).
Trajanje delovanja sestavine zdravila Liprolog Mix50 suspenzije insulina lispro-protamin (Basal) je podobno kot pri bazalnem insulinu (NPH).
The duration of action of the insulin lispro protamine suspension (Basal) component of Liprolog Mix50 is similar to that of a basal insulin NPH.
Trajanje delovanja sestavine zdravila Liprolog Mix50 suspenzije insulina lispro-protamin (Basal) je podobno kot pri bazalnem insulinu (NPH).
The duration of assessment ended at the last available measurement or at the day of medical intervention for joints that did not recur and the recurrence day for recurrent joints. b A recurrent joint was a joint evaluated by the investigator as having a worsening Dupuytren's contracture due to a palpable cord.
Trajanje ocenjevanja se je končalo z zadnjo razpoložljivo meritvijo ali na dan zdravniškega posega za sklepe, pri katerih ni bilo ponovitve, in dan ponovitve za sklepe, pri katerih je do ponovitve prišlo. b Sklep, pri katerem je prišlo do ponovitve, je bil sklep, ki ga je raziskovalec ocenil s poslabšanjem Dupuytrenove kontrakture zaradi otipljivega vozliča.
The duration of combination therapy with ribavirin for chronic hepatitis C depends on viral genotype.
Trajanje kombiniranega zdravljenja z ribavirinom pri kroničnem hepatitisu C je odvisno od virusnega genotipa.
The duration of combination treatment in children varies from 6 to 12 months depending on the type of virus your child is infected with and their response to therapy.
Trajanje kombiniranega zdravljenja pri otrocih poteka od 6 do 12 mesecev, odvisno od tipa virusa, s katerim je okužen vaš otrok, in njihovega odziva na zdravljenje.
The duration of double-blind therapy was 16 weeks in study AC-052-401, and 24 weeks in study AC-052- 331.
Dvojno slepa terapija je v študiji AC-052-401 trajala 16 tednov in v študiji AC-052-331 24 tednov.
The duration of efficacy may be reduced if the dose is administered on an empty stomach.
Trajanje učinkovitosti se lahko zmanjša, če se odmerek daje na prazen želodec.
The duration of immunity after the last re-vaccination is 3 years for rhinotracheitis, calicivirosis and panleucopenia components.
Trajanje imunosti po zadnjem ponovnem cepljenju je 3 leta za komponente kužnega rinotraheitisa, kaliciviroze in mačje panleukopenije.
The duration of immunity after the last re-vaccination is 3 years for the rhinotracheitis, calicivirosis and panleucopenia components, and 1 year for the Chlamydophila felis component.
Trajanje imunosti je 3 leta po zadnjem ponovnem cepljenju za komponente kužnega rinotraheitisa, kaiciviroze in panleukopenije, ter 1 leto za komponento Chlamydophila felis.
The duration of immunity against CAV-2 was not established by challenge.
Trajanje imunosti proti CAV- 2 ni bilo določeno s preizkusom.
The duration of immunity against CAV-2 was not established by challenge.
Trajanje imunosti proti CAV-2 s preizkusom ni bilo določeno.
The duration of immunity for cattle and sheep is 1 year after primary vaccination course.
Trajanje imunosti pri govedu in ovcah je 1 leto po osnovnem cepljenju.
The duration of immunity for cattle and sheep is 1 year after the primary vaccination course.
Trajanje imunosti pri govedu inpri ovcah 1 leto po osnovnem cepljenju.
The duration of immunity is 1 year after primary vaccination course.
Trajanje imunosti 1 leto po osnovnem cepljenju.
The duration of immunity is one year after the primary vaccination for all components.
Trajanje imunosti je eno leto po prvem cepljenju za vse sestavine.
The duration of immunity is one year after the primary vaccination.
Trajanje imunosti je eno leto po prvem cepljenju.
The duration of immunity to reduce the number of eggs with abnormal shell formation has not yet been demonstrated
Trajanje imunosti za zmanjševanje števila jajc z nenormalno oblikovano lupino še ni bilo dokazano.
The duration of immunity: 12 months.
Trajanje imunosti: 12 mesecev.
The duration of overall response was 21.4 months longer in the BR-CAP group (median
Trajanje celokupnega odgovora je bilo 21,4 mesecev daljše v skupini BzR-CAP (mediana
The duration of post-treatment prophylaxis should be based on clinical judgment and may take into account a patient’s risk factors such as concomitant corticosteroid treatment and prolonged neutropenia (see section 4.8).
Trajanje profilakse po zdravljenju mora biti odvisno od zdravniške presoje in lahko upošteva dejavnike tveganja bolnika, kot sta sočasno zdravljenje s kortikosteroidi in dolgotrajna nevtropenija (glejte poglavje 4.8).
The duration of postvaccinal immunity to homologous strains or to strains closely related to the vaccine strains varies but is usually 6-12 months.
Po cepljenju se trajanje imunosti na homologne seve ali na seve, ki so tesno povezani s sevi cepiva, razlikuje, običajno pa traja od 6 do 12 mesecev.
The duration of respiratory depression following overdose may be longer than the effects of the opioid antagonist’s action (e.g. the half life of naloxone ranges from 30 to 81 minutes) and repeated administration may be necessary.
Depresija dihanja po prevelikem odmerku lahko traja dlje kot učinki opioidnega antagonista (npr. razpolovni čas naloksona je 30 do 81 minut) in je zato lahko potrebna ponavljajoča se uporaba.
The duration of respiratory depression following overdose may be longer than the effects of the opioid antagonist’s action (e.g., the half-life of naloxone ranges from 30 to 81 minutes) and repeated administration may be necessary.
Trajanje respiratorne depresije po prevelikem odmerku je lahko daljše kot učinek delovanja opioidnega antagonista (npr. razpolovna doba naloksona niha med 30 in
The duration of response was 16 weeks (CI: 13, 19) and the time to next CLL therapy was 52.4 weeks (CI: 36.9 – non-estimable).
Odziv je trajal 16 tednov (IZ: od 13,3 do 19), čas do naslednjega zdravljenja KLL pa je bil 52,4 tedna (IZ: od 36,9 do neocenljivo).
The duration of response was 16 weeks (CI: 13.3, 19) and the time to next CLL therapy was 52.4 weeks (CI: 36.9 – non-estimable).
Odziv je trajal 16 tednov (IZ: od 13,3 do 19), čas do naslednjega zdravljenja KLL pa je bil 52,4 tedna (IZ: od 36,9 do neocenljivo).
The duration of the administration is approximately 5 minutes
Trajanje aplikacije je približno 5 minut.
The duration of the administration is approximately 5 minutes.
Trajanje dajanja je približno 5 minut.
The duration of the administration of these medicines will depend on your response and treatment plan.
Čas jemanja teh zdravil bo odvisen od vašega odziva in načrta zdravljenja.
The duration of the effect is approximately 24 hours and, therefore, tablets can be given the night before administration of an agent that may cause emesis (e.g. chemotherapy).
Učinek traja približno 24 ur, zato lahko tablete damo večer pred dajanjem zdravila, ki bi lahko povzročilo slabost (na primer kemoterapija).
The duration of the useful imaging time is 2.5 - 4.5 minutes for a dose of 0.5 - 3.0 ml.
Trajanje uporabnega časa za slikanje je 2,5 - 4,5 minut pri odmerku 0,5 - 3,0 ml.
The duration of the useful imaging time is 2.5 - 4.5 minutes for a dose of 0.5 - 3.0 ml.
Čas trajanja uporabnega slikanja je 2,5 – 4,5 minut za odmerek 0,5 – 3,0 ml.
The duration of therapy for treatment of DVT and PE (venous thromboembolism, VTE), and prevention of recurrent VTE should be individualised after careful assessment of the treatment benefit against the risk for bleeding (see section 4.4).
Trajanje terapije za zdravljenje GVT in PE (venske tromboembolije, VTE) in preprečevanje ponovne VTE se določi individualno po skrbni oceni koristi zdravljenja glede na tveganje za krvavitve (glejte poglavje 4.4).
The duration of therapy is based on recovery from neutropenia or immunosuppression.
Trajanje zdravljenja je odvisno od okrevanja po nevtropeniji ali imunosupresiji.
The duration of therapy may need to be longer than 14 days in accordance with the perceived risk of complications in the individual patient.
Glede na pričakovano možnost zapletov pri posameznem bolniku je trajanje zdravljenja lahko daljše kot 14 dni.
The duration of therapy should be guided by the severity, site of the infection, and the patient’s clinical response.
Trajanje zdravljenja je odvisno od resnosti okužbe, mesta okužbe in bolnikovega kliničnega odziva.
The duration of therapy should be individualised after careful assessment of the treatment benefit against the risk for bleeding (see section 4.4).
Trajanje zdravljenja je treba po skrbni presoji med koristijo zdravljenja in tveganjem krvavitve individualno prilagoditi (glejte poglavje 4.4).
The duration of therapy should be individualised after careful assessment of the treatment benefit against the risk for bleeding (see section 4.4).
Trajanje zdravljenja se določi individualno po skrbni oceni koristi zdravljenja glede na tveganje za krvavitve (glejte poglavje 4.4).
The duration of therapy was 48 weeks with a follow-up period of 6 months except for patients infected with genotypes 2 or 3 and viral load
spremljanja bolnikov, razen pri tistih, ki so bili okuženi z genotipoma 2 ali 3 in so imeli virusno breme
The duration of therapy was 48 weeks with a follow-up period of 6 months except for patients infected with genotypes 2 or 3 and viral load
Zdravljenje je trajalo 48 tednov, z nadaljnjim 6-mesečnim obdobjem spremljanja bolnikov, razen pri tistih, ki so bili okuženi z genotipoma 2 ali 3 in so imeli virusno breme
The duration of these pharmacodynamic effects is consistent with the drug’s elimination half-life.
Trajanje teh farmakodinamičnih učinkov je skladno z eliminacijskim razpolovnim časom zdravila.
The duration of treatment and the interval between injections will vary with the severity of the haemorrhage, the invasive procedures or surgery being performed.
Trajanje zdravljenja in interval med injekcijami se razlikuje glede na to, kako huda je krvavitev, invazivni postopek ali operacija.
The duration of treatment and the interval between injections will vary with the severity of the haemorrhage, the invasive procedures or the surgery being performed.
Trajanje zdravljenja in presledek med injekcijami se razlikujeta glede na izrazitost krvavitve oz. potrebne invazivne postopke ali operacijo.
The duration of treatment beyond 24 weeks should be subject to the physicians discretion based upon the patient response and maintenance response in the long-term.
Odločitev o trajanju zdravljenja več kot 24 tednov je v presoji zdravnika na podlagi bolnikovega odziva in dolgoročnega vzdrževalnega odziva.
The duration of treatment can last up to 5 days.
Zdravljenje lahko traja do 3 dni.
The duration of treatment depends on clinical status and is left to the physician’s discretion.
Trajanje zdravljenja je odvisno od kliničnega stanja in je prepuščeno presoji zdravnika.
The duration of treatment depends on the dog’s response to treatment.
Trajanje zdravljenja je odvisno od odziva psa na zdravljenje.
The duration of treatment depends on the nature and severity of the infection and on the response seen.
Trajanje zdravljenja je odvisno od oblike in resnosti okužbe ter od odzivnosti na zdravljenje.
The duration of treatment depends on the patient’s condition and response to treatment, and ranges from 24 weeks to a year.
Trajanje zdravljenja je odvisno od bolnikovega stanja in odziva na zdravljenje, in sicer od 24 tednov do enega leta.
The duration of treatment depends on the patient’s condition and response to treatment, and ranges from six months to a year.
Trajanje zdravljenja je odvisno od bolnikovega stanja in odziva na zdravljenje ter traja od šestih mesecev do enega leta.
The duration of treatment depends on the patient’s condition and response to treatment.
Trajanje zdravljenja je odvisno od bolnikovega stanja in odziva na zdravljenje.
The duration of treatment depends on the patient’s condition.
Trajanje zdravljenja je odvisno od bolnikovega stanja.
The duration of treatment depends on the risk of complications and official recommendations.
Trajanje zdravljenja je odvisno od pričakovanih zapletov in uradnih priporočil.
The duration of treatment depends on the severity of the disease and the patient’s response.
Trajanje zdravljenja je odvisno od resnosti bolezni in bolnikovega odziva.
The duration of treatment depends on the severity of the infection and how well the medicine works in your pet.
Trajanje zdravljenja je odvisno od vrste in težavnosti okužbe ter samega poteka zdravljenja.
The duration of treatment in Phase 2 and 3 studies ranged from 6 weeks to 64 weeks.
Zdravljenje v študijah faze 2 in 3 je trajalo od 6 tednov do 64 tednov.
The duration of treatment is adjusted depending on the patient’s blood levels of uric acid and the doctor’s judgment.
Trajanje zdravljenja se prilagodi glede na bolnikove koncentracije sečne kisline v krvi in v skladu z zdravnikovo presojo.
The duration of treatment is dependent on clinical response.
Trajanja zdravljenja je odvisno od kliničnega odziva.
The duration of treatment is up to 1 year based on the doctor’s judgement for you, or the child you are caring for.
Vaše zdravljenje ali zdravljenje otroka, za katerega skrbite, traja do 1 leta, odvisno od zdravnikove presoje.
The duration of treatment will depend on the horse’s response, but should not exceed 14 days.
Trajanje zdravljenja je odvisno od odziva konja, vendar ne sme trajati dlje kot 14 dni.
The duration of treatment with Harvoni and whether it is used alone or in combination with another medicine called ribavirin depends on the genotype of the virus and the nature of the liver problems patients have, for example if they have liver cirrhosis (scarring) or their liver is not working properly.
Odločitev o trajanju zdravljenja z zdravilom Harvoni in o tem, ali se bo uporabljalo kot samostojno zdravilo ali v kombinaciji z drugim zdravilom, imenovanim ribavirin, je odvisna od genotipa virusa in vrste bolnikovih težav z jetri, kot sta ciroza jeter (brazgotinjenje) ali njihovo nepravilno delovanje.